• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胞苷环戊烯基类似物对人早幼粒细胞白血病细胞系HL-60的诱导分化作用

Induction of differentiation in the human promyelocytic leukemia cell line HL-60 by the cyclopentenyl analogue of cytidine.

作者信息

Glazer R I, Cohen M B, Hartman K D, Knode M C, Lim M I, Marquez V E

出版信息

Biochem Pharmacol. 1986 Jun 1;35(11):1841-8. doi: 10.1016/0006-2952(86)90301-1.

DOI:10.1016/0006-2952(86)90301-1
PMID:3459463
Abstract

The effects of the cyclopentenyl (cCyd) and cyclopentyl (carbodine) analogues of cytidine on differentiation, and nucleic acid and nucleotide biosynthesis, were examined in the human promyelocytic leukemia cell line HL-60. Continuous exposure for 5 days to 10(-8) to 10(-6) M cCyd or 10(-6) to 10(-5) M carbodine produced progressive inhibition of cell growth. During this exposure interval, pronounced differentiation to mature myeloid cells occurred wherein 95% of the cell population reduced nitroblue tetrazolium 4 days after exposure to 10(-7) M cCyd or 10(-5) M carbodine. Preceding differentiation was the inhibition of DNA synthesis which reached 10% of control levels 24 hr after exposure to 10(-7) M cCyd or 10(-5) M carbodine, while RNA synthesis was inhibited to a lesser extent. The induction of mature myeloid cells by cCyd was preceded by the inhibition of c-myc mRNA levels which was more pronounced than the reduction in total cellular RNA synthesis. During the interval of cCyd treatment, there was a rapid and pronounced inhibition in the level of CTP, but not of UTP, ATP or GTP, where the half-life for the disappearance of CTP was 1.5 to 2 hr. Following drug removal, cells treated with cCyd showed a sustained reduction in CTP levels, whereas cells treated with carbodine showed almost complete recovery of CTP levels within 48 hr. These results indicate that the reduction in CTP levels leads to rapid inhibition of DNA synthesis and reduction in c-myc mRNA levels which precede the appearance of differentiated cells.

摘要

在人早幼粒细胞白血病细胞系HL-60中,研究了胞苷的环戊烯基(cCyd)和环戊基(卡波定)类似物对细胞分化以及核酸和核苷酸生物合成的影响。将细胞连续暴露于10^(-8)至10^(-6) M的cCyd或10^(-6)至10^(-5) M的卡波定5天,可产生对细胞生长的渐进性抑制。在此暴露期间,细胞明显分化为成熟的髓样细胞,其中在暴露于10^(-7) M的cCyd或10^(-5) M的卡波定4天后,95%的细胞群体能使硝基蓝四氮唑还原。在分化之前,DNA合成受到抑制,在暴露于10^(-7) M的cCyd或10^(-5) M的卡波定24小时后,DNA合成降至对照水平的10%,而RNA合成受到的抑制程度较小。cCyd诱导成熟髓样细胞之前,c-myc mRNA水平受到抑制,且这种抑制比总细胞RNA合成的减少更为明显。在cCyd处理期间,CTP水平迅速且显著降低,但UTP、ATP或GTP水平未受影响,CTP消失的半衰期为1.5至2小时。去除药物后,用cCyd处理的细胞CTP水平持续降低,而用卡波定处理的细胞在48小时内CTP水平几乎完全恢复。这些结果表明,CTP水平的降低导致DNA合成迅速受到抑制以及c-myc mRNA水平降低,这发生在分化细胞出现之前。

相似文献

1
Induction of differentiation in the human promyelocytic leukemia cell line HL-60 by the cyclopentenyl analogue of cytidine.胞苷环戊烯基类似物对人早幼粒细胞白血病细胞系HL-60的诱导分化作用
Biochem Pharmacol. 1986 Jun 1;35(11):1841-8. doi: 10.1016/0006-2952(86)90301-1.
2
Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells.
Biochem Pharmacol. 1985 Jul 15;34(14):2535-9. doi: 10.1016/0006-2952(85)90539-8.
3
Effect of neplanocin A on differentiation, nucleic acid methylation, and c-myc mRNA expression in human promyelocytic leukemia cells.
Mol Pharmacol. 1985 Jul;28(1):45-50.
4
Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
Biochem Pharmacol. 1992 Apr 1;43(7):1587-99. doi: 10.1016/0006-2952(92)90218-8.
5
Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Mol Pharmacol. 1987 Feb;31(2):140-5.
6
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.莫特4型淋巴母细胞对环戊烯基胞嘧啶(CPE-C)的耐药机制。
Biochem Pharmacol. 1993 Apr 6;45(7):1493-501. doi: 10.1016/0006-2952(93)90050-7.
7
Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.镁缺乏会抑制人早幼粒细胞白血病HL-60细胞中分化相关表型的表达。
J Cell Physiol. 1987 Apr;131(1):50-7. doi: 10.1002/jcp.1041310109.
8
Cooperative effects of tumor necrosis factor-alpha and 1,25-dihydroxyvitamin D3 on growth inhibition, differentiation, and c-myc reduction in human promyelocytic leukemia cell line HL-60.肿瘤坏死因子-α与1,25-二羟基维生素D3对人早幼粒细胞白血病细胞系HL-60生长抑制、分化及c-myc表达下调的协同作用
Biochem Biophys Res Commun. 1988 May 16;152(3):1151-7. doi: 10.1016/s0006-291x(88)80405-4.
9
Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.一种对1-β-D-阿拉伯呋喃糖基胞嘧啶具有高度抗性的脱氧胞苷激酶缺陷型人早幼粒细胞白血病细胞系的分离与鉴定
Cancer Res. 1984 Nov;44(11):5029-37.
10
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.1,25-二羟基维生素D3诱导人早幼粒细胞白血病细胞系(HL-60)分化:受体介导的向巨噬细胞样细胞的成熟。
J Cell Biol. 1984 Feb;98(2):391-8. doi: 10.1083/jcb.98.2.391.

引用本文的文献

1
In vitro characterization of the myelotoxicity of cyclopentenyl cytosine.环戊烯基胞嘧啶骨髓毒性的体外特性研究
Cancer Chemother Pharmacol. 1994;34(2):103-8. doi: 10.1007/BF00685926.
2
Phase I clinical trial of continuous infusion cyclopentenyl cytosine.持续输注环戊烯基胞嘧啶的I期临床试验。
Cancer Chemother Pharmacol. 1995;36(6):513-23. doi: 10.1007/BF00685802.
3
Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kinetics.环戊烯基胞嘧啶:基于啮齿动物血浆和尿液动力学的种间预测
Invest New Drugs. 1991 Feb;9(1):9-17. doi: 10.1007/BF00194539.
4
Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.环戊烯基胞嘧啶的广谱抗病毒和杀细胞活性,一种靶向CTP合成酶的碳环核苷。
Biochem Pharmacol. 1991 Jun 15;41(12):1821-9. doi: 10.1016/0006-2952(91)90120-t.
5
Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine.胞苷的碳环类似物卡波定的广谱抗病毒活性。
Biochem Pharmacol. 1990 Jan 15;39(2):319-25. doi: 10.1016/0006-2952(90)90031-f.